<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>7539</number>
    <updateDate>2024-08-21T08:05:17Z</updateDate>
    <updateDateIncludingText>2024-08-21T08:05:17Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2024-03-05</introducedDate>
    <congress>118</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 170, Number 39 (Tuesday, March 5, 2024)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. FITZPATRICK:H.R. 7539.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18The single subject of this legislation is:To require the Secretary of the Treasury to guaranteeBioBonds in order to provide funding for loans to eligiblebiomedical companies and universities to carry out clinicaltrials approved by the Food and Drug Administration, and forother purposes.[Page H822]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2024-03-08T20:15:21Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2024-03-05T17:03:25Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2024-03-08</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-03-05</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-03-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-03-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>F000466</bioguideId>
        <fullName>Rep. Fitzpatrick, Brian K. [R-PA-1]</fullName>
        <firstName>Brian</firstName>
        <lastName>Fitzpatrick</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>K.</middleName>
        <district>1</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B000490</bioguideId>
        <fullName>Rep. Bishop, Sanford D. [D-GA-2]</fullName>
        <firstName>Sanford</firstName>
        <lastName>Bishop</lastName>
        <party>D</party>
        <state>GA</state>
        <middleName>D.</middleName>
        <district>2</district>
        <sponsorshipDate>2024-03-05</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000250</bioguideId>
        <fullName>Rep. Sessions, Pete [R-TX-17]</fullName>
        <firstName>Pete</firstName>
        <lastName>Sessions</lastName>
        <party>R</party>
        <state>TX</state>
        <district>17</district>
        <sponsorshipDate>2024-04-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000487</bioguideId>
        <fullName>Rep. Tokuda, Jill N. [D-HI-2]</fullName>
        <firstName>Jill</firstName>
        <lastName>Tokuda</lastName>
        <party>D</party>
        <state>HI</state>
        <middleName>N.</middleName>
        <district>2</district>
        <sponsorshipDate>2024-05-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001172</bioguideId>
        <fullName>Rep. Smith, Adrian [R-NE-3]</fullName>
        <firstName>Adrian</firstName>
        <lastName>Smith</lastName>
        <party>R</party>
        <state>NE</state>
        <district>3</district>
        <sponsorshipDate>2024-05-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000583</bioguideId>
        <fullName>Rep. Gottheimer, Josh [D-NJ-5]</fullName>
        <firstName>Josh</firstName>
        <lastName>Gottheimer</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>5</district>
        <sponsorshipDate>2024-06-25</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001296</bioguideId>
        <fullName>Rep. Boyle, Brendan F. [D-PA-2]</fullName>
        <firstName>Brendan</firstName>
        <lastName>Boyle</lastName>
        <party>D</party>
        <state>PA</state>
        <middleName>F.</middleName>
        <district>2</district>
        <sponsorshipDate>2024-06-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000593</bioguideId>
        <fullName>Rep. Levin, Mike [D-CA-49]</fullName>
        <firstName>Mike</firstName>
        <lastName>Levin</lastName>
        <party>D</party>
        <state>CA</state>
        <district>49</district>
        <sponsorshipDate>2024-07-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001190</bioguideId>
        <fullName>Rep. Schneider, Bradley Scott [D-IL-10]</fullName>
        <firstName>Bradley</firstName>
        <lastName>Schneider</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>Scott</middleName>
        <district>10</district>
        <sponsorshipDate>2024-08-20</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Health</name>
        <updateDate>2024-03-27T20:15:23Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2024-03-05</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-07-24T21:00:34Z</updateDate>
        <text><![CDATA[<p><strong>Long-term Opportunities for Advancing New Studies for Biomedical Research Act or the LOANS for Biomedical Research Act</strong></p><p>This bill requires the Department of the Treasury to establish the BioBonds Program to support loans for clinical trials for eligible drugs and medical devices for unmet medical needs.</p><p>Under the program, fiscal agents purchase loans (up to $25 million per recipient) and issue collateralized bonds that are sold to investors and that are guaranteed by Treasury.&nbsp;An eligible borrower under this program is one conducting (or seeking to conduct) research related to a drug or device that is (1) intended to meet an unmet medical need; and (2) under investigation in certain types of controlled clinical trials, including a trial to investigate the safety and effectiveness of the drug or device.&nbsp;</p><p>The Government Accountability Office (GAO) and Treasury must report on the program; GAO must also study whether similar programs should be established for other biomedical research projects.</p><p>&nbsp;</p>]]></text>
      </summary>
    </summaries>
    <title>LOANS for Biomedical Research Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>LOANS for Biomedical Research Act</title>
        <updateDate>2024-07-24T15:19:01Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>LOANS for Biomedical Research Act</title>
        <updateDate>2024-05-24T13:33:52Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Long-term Opportunities for Advancing New Studies for Biomedical Research Act</title>
        <updateDate>2024-05-24T13:33:52Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To require the Secretary of the Treasury to guarantee BioBonds in order to provide funding for loans to eligible biomedical companies and universities to carry out clinical trials approved by the Food and Drug Administration, and for other purposes.</title>
        <updateDate>2024-03-18T22:21:45Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2024-03-05T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr7539ih/xml/BILLS-118hr7539ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2024-03-08</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
